Phibro Animal Health (PAHC) EPS (Basic) Growth (3y) (2015 - 2026)
Phibro Animal Health (PAHC) EPS (Basic) Growth (3y) (2015 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EPS (Basic) Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.85 Bn | 42.88 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 43.02 Bn | 39.37 Bn | 2.15 Bn | 15.17% |
| 3 | Zoetis | 31.47 Bn | 29.79 Bn | 1.05 Bn | 3.18% |
| 4 | Takeda Pharmaceutical | 28.59 Bn | 22.79 Bn | 5.10 Bn | 2.42% |
| 5 | United Therapeutics | 22.20 Bn | 19.53 Bn | 683.80 Mn | 12.25% |
| 6 | Viatris | 18.76 Bn | 17.87 Bn | 1.46 Bn | -35.06% |
| 7 | Neurocrine Biosciences | 15.45 Bn | 15.06 Bn | 935.80 Mn | 13.47% |
| 8 | Elanco Animal Health | 11.76 Bn | 11.23 Bn | 798.00 Mn | 36.60% |
| 9 | Dr Reddys Laboratories | 10.10 Bn | 9.94 Bn | - | - |
| 10 | Phibro Animal Health | 1.43 Bn | 1.35 Bn | 125.68 Mn | 33.69% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 33.69% |
| Dec 31, 2025 | 56.13% |
| Sep 30, 2025 | 90.14% |
| Jun 30, 2025 | 32.00% |
| Mar 31, 2025 | 5.67% |
| Dec 31, 2024 | -43.29% |
| Sep 30, 2024 | 2.20% |
| Jun 30, 2024 | -26.06% |
| Mar 31, 2024 | -11.60% |
| Dec 31, 2023 | -53.68% |
| Sep 30, 2023 | -38.40% |
| Jun 30, 2023 | 26.00% |
| Mar 31, 2023 | -9.43% |
| Dec 31, 2022 | -15.40% |
| Sep 30, 2022 | 15.26% |
| Jun 30, 2022 | -89.79% |
| Mar 31, 2022 | -89.40% |
| Dec 31, 2021 | -89.43% |
| Sep 30, 2021 | -92.64% |
| Jun 30, 2021 | -19.30% |